LactSafeFor educational purposes only — always consult your healthcare provider.
🤰 Pregnancy Safety
Adalimumab
Humira
Adalimumab is not expected to significantly increase the risk of miscarriage or birth defects, but more crosses the placenta in the third trimester.
Need more information before deciding?
- Safer alternatives to consider
- Why this rating — the full evidence
- Known risks & trimester considerations
- Breastfeeding safety info
Free · No account required